As noted in the discussion of the results of this clinical trial, elevated levels of parathyroid hormone (PTH) are a non-traditional risk factor for CVD.30 Primary hyperparathyroidism is associated with hypertension, coronary atherosclerosis and other cardiovascular diseases.